Remibrutinib Demonstrates Superior Efficacy in Relapsing MS: A Milestone in BTK Inhibition
By Judy George, Deputy Managing Editor, MedPage Today October 25, 2026 In a significant development for the landscape of multiple sclerosis (MS) treatment, new phase III clinical data suggests that…










